[Therapy of vascular-dependent skin pathology].
The therapeutic results obtained with twice daily medication with 3% hydrocortisone bendazac ester cream are indicated. This therapy was found to be effective particularly in photodermatoses radiation dermatitis and superficial vascular skin disorders. Moreover, it is also very useful for varicose veins and phlebitis, photoactive eczema and burns, since it can limit the necrotic evolution, correct excessive granulation tissue formation and control the tendency towards the development of keloids.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002056:Burns / Q000188:drug therapy; D004338:Drug Combinations; D006801:Humans; D006854:Hydrocortisone; D007191:Indazoles / Q000627:therapeutic use*; D010787:Photosensitivity Disorders / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014648:Varicose Veins / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D007191:Indazoles; D011720:Pyrazoles; C000123:bendazac; D006854:Hydrocortisone
Terapia della patologia cutanea vasculo-dipendente.